结合有机框架 化用于精确的磁共振成像 癌症诊断
Sixue Ouyang1, Chuyao Chen2, Peiru Lin3
1School of Chemistry and Chemical Engineering, South China University of Technology, 510640 Guangzhou, China.
Nano letters
|September 11, 2023
概括
一种新的MRI对比剂,PFC-73-Mn,为癌症诊断提供了高性能. 这种新药物需要较低的剂量,并显示出早期瘤成像的前景.
科学领域:
- 生物医学成像学 生物医学成像学
- 材料科学是一种材料科学.
- 纳米技术 纳米技术
背景情况:
- 磁共振成像 (MRI) 对于癌症诊断至关重要.
- 目前的加多基对比剂具有局限性,包括高剂量要求和潜在的不良影响.
- 开发更安全,更有效的MRI对比剂是持续的研究重点.
研究的目的:
- 开发一种基于与结合的有机框架的新型MRI对比剂.
- 评估新药PFC-73-Mn在增强癌症成像中的有效性.
- 评估PFC-73-Mn作为现有对比剂的优质替代品的潜力.
主要方法:
- 一种以结合的有机框架为基础的MRI对比剂 (PFC-73-Mn) 的合成.
- 在3.0T临床MRI扫描仪下评估纵向放松 (r1) 特性.
- 在临床前癌症模型中对PFC-73-Mn进行体内测试,包括乳腺瘤和质瘤.
主要成果:
- 由于水分子相互作用和受限制的离子旋转,PFC-73-Mn表现出高的纵向放松 (r1 = 5.03 mM-1 s-1).
- 通过显著降低PFC-73-Mn的静脉注射剂量 (8μmol Mn/kg),可以实现强烈的对比度增强.
- 实现了多种癌症类型的准确诊断,包括乳腺瘤和超小的正经质瘤.
结论:
- 与现有药物相比,PFC-73-Mn作为MRI对比剂表现出优越的性能.
- 该药物在低剂量的高疗效和在瘤成像中的广泛适用性是显著的进步.
- 通过增强的MRI,PFC-73-Mn显示了改善早期癌症检测和诊断的巨大潜力.
相关概念视频
01:24Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K
01:25Applications Of NMR In Biology
3.7K
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
3.7K